Patents by Inventor VANCE GARDNER

VANCE GARDNER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240415932
    Abstract: The invention relates to systems and methods for the diagnosis, amelioration, and treatment of ischemic tissues in patients caused by and/or resulting from diminished microvascular blood flow. Patients suffering from ischemic tissue conditions can be categorized into specific subsets that are deemed to have a potential to respond to therapy. In particular, the invention includes various therapies involving stimulation of angiogenesis, vasculogenesis, arteriogenesis and/or neovascularization so as to increase perfusion of various tissues.
    Type: Application
    Filed: August 26, 2024
    Publication date: December 19, 2024
    Inventors: Vance Gardner, Hon Yu, Kenneth A. Thomas, Thomas J. Stegmann, John W. Jacobs, Tugan Muftuler, Shadfar Bahri
  • Patent number: 12168038
    Abstract: The invention relates to systems and methods for the diagnosis, amelioration, and treatment of ischemic tissues in patients caused by and/or resulting from diminished microvascular blood flow. Patients suffering from ischemic tissue conditions can be categorized into specific subsets that are deemed to have a potential to respond to therapy. In particular, the invention includes various therapies involving stimulation of angiogenesis, vasculogenesis, arteriogenesis and/or neovascularization so as to increase perfusion of various tissues.
    Type: Grant
    Filed: April 13, 2020
    Date of Patent: December 17, 2024
    Assignee: VENTURIS THERAPEUTICS, INC.
    Inventors: Vance Gardner, Hon Yu, Kenneth A. Thomas, Thomas J. Stegmann, John W. Jacobs, Tugan Muftuler, Shadfar Bahri
  • Publication number: 20220323125
    Abstract: Disclosed are devices, systems and related surgical methods for improving the fixation and/or durability of bone implants and/or components thereof for fracture fixation and/or other orthopedic procedures.
    Type: Application
    Filed: April 6, 2022
    Publication date: October 13, 2022
    Inventors: Matthew DUFFIN, Vance GARDNER, Robert S. GORAB, Carlos A. PRIETTO, Edward QUILLIGAN
  • Publication number: 20220323116
    Abstract: Disclosed are devices, systems and related surgical methods for improving the fixation and/or durability of bone implants and/or components thereof for cervical fracture fixation and/or other orthopedic procedures.
    Type: Application
    Filed: April 28, 2022
    Publication date: October 13, 2022
    Inventors: Vance GARDNER, Gerald ALEXANDER, Matthew DUFFIN, Robert GORAB, Ryan HELBER, Oluwadamilola OLUYEDE, Edward QUILLIGAN, Carlos PRIETTO, Jeremy SMITH, Jon WHITE
  • Patent number: 11224635
    Abstract: Methods for the diagnosis and treatment of ischemic spinal conditions, degenerative disc disease, back pain and/or other tissue pathologies. Patients with ischemic spine disease can be categorized into subsets that are deemed to have potential to respond to therapy. In particular, therapies are disclosed which involve stimulation of neovascularization so as to increase perfusion of spinal and other anatomies.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: January 18, 2022
    Assignees: Venturis Thereuptics, Inc.
    Inventors: Vance Gardner, Hon Yu, Kenneth A. Thomas, Thomas J. Stegmann, John W. Jacobs, Tugan Muftuler, Shadfar Bahri, Edwin Anderson
  • Publication number: 20210212565
    Abstract: Devices, methods, systems and procedures for localized, targeted treatment of angiogenic-based therapy in at least one region of interest in one or more layers of cardiac tissue. Various methods can include diagnosing a patient with ischemic heart disease or “at-risk” of manifesting ischemic heart disease, placing the patient into a specific angiogenic-based treatment therapy group, collecting image data, confirming image data and other diagnostic test results, developing a preoperative plan to target region of interest, inserting the catheter into a heart chamber, monitoring the distal end of the catheter tip within the heart on a visual display, contacting at least one layer of cardiac tissue, creating one or more channels in the heart tissue and/or administering the angiogenic-based therapy.
    Type: Application
    Filed: March 31, 2021
    Publication date: July 15, 2021
    Inventors: Vance Gardner, Kenneth Thomas, John Jacobs, Thomas Stegmann, Mickael Flaa, Laurence R. Meyerson
  • Patent number: 10966610
    Abstract: Devices, methods, systems and procedures for localized, targeted treatment of angiogenic-based therapy in at least one region of interest in one or more layers of cardiac tissue. Various methods can include diagnosing a patient with ischemic heart disease or “at-risk” of manifesting ischemic heart disease, placing the patient into a specific angiogenic-based treatment therapy group, collecting image data, confirming image data and other diagnostic test results, developing a preoperative plan to target region of interest, inserting the catheter into a heart chamber, monitoring the distal end of the catheter tip within the heart on a visual display, contacting at least one layer of cardiac tissue, creating one or more channels in the heart tissue and/or administering the angiogenic-based therapy.
    Type: Grant
    Filed: July 5, 2017
    Date of Patent: April 6, 2021
    Assignees: Venturis Therapeutics, Inc.
    Inventors: Vance Gardner, Kenneth Thomas, John Jacobs, Thomas Stegmann, Mickael Flaa, Laurence R. Meyerson
  • Publication number: 20200237873
    Abstract: The invention relates to systems and methods for the diagnosis, amelioration, and treatment of ischemic tissues in patients caused by and/or resulting from diminished microvascular blood flow. Patients suffering from ischemic tissue conditions can be categorized into specific subsets that are deemed to have a potential to respond to therapy. In particular, the invention includes various therapies involving stimulation of angiogenesis, vasculogenesis, arteriogenesis and/or neovascularization so as to increase perfusion of various tissues.
    Type: Application
    Filed: April 13, 2020
    Publication date: July 30, 2020
    Inventors: Vance Gardner, Hon Yu, Kenneth A. Thomas, Thomas J. Stegmann, John W. Jacobs, Tugan Muftuler, Shadfar Bahri
  • Patent number: 10624952
    Abstract: The invention relates to systems and methods for the diagnosis, amelioration, and treatment of ischemic tissues in patients caused by and/or resulting from diminished microvascular blood flow. Patients suffering from ischemic tissue conditions can be categorized into specific subsets that are deemed to have a potential to respond to therapy. In particular, the invention includes various therapies involving stimulation of angiogenesis, vasculogenesis, arteriogenesis and/or neovascularization so as to increase perfusion of various tissues.
    Type: Grant
    Filed: December 17, 2014
    Date of Patent: April 21, 2020
    Assignees: CardioVascular BioTherapeutics, Inc.
    Inventors: Vance Gardner, Hon Yu, Kenneth A. Thomas, Thomas J. Stegmann, John W. Jacobs, Tugan Muftuler, Shadfar Bahri
  • Patent number: 10433783
    Abstract: Disclosed are devices, methods and surgical procedures for detecting, imaging, analyzing, diagnosing and/or treating vascular disorders and related conditions of the human and mammalian body in males and/or females. In particular embodiments, treatments include methods for imaging, analyzing and improving erectile dysfunction and related conditions and potentially increasing angiogenesis in response to specifically diagnosed conditions.
    Type: Grant
    Filed: April 25, 2018
    Date of Patent: October 8, 2019
    Assignees: CardioVascular BioTherapeutics, Inc.
    Inventors: Vance Gardner, Mickael Flaa, Laurence R Meyerson, John Jacobs
  • Publication number: 20190029589
    Abstract: Disclosed are devices, methods and surgical procedures for detecting, imaging, analyzing, diagnosing and/or treating vascular disorders and related conditions of the human and mammalian body in males and/or females. In particular embodiments, treatments include methods for imaging, analyzing and improving erectile dysfunction and related conditions and potentially increasing angiogenesis in response to specifically diagnosed conditions.
    Type: Application
    Filed: April 25, 2018
    Publication date: January 31, 2019
    Inventors: Vance Gardner, Mickael Flaa, Laurence R. Meyerson, John Jacobs
  • Patent number: 9968292
    Abstract: Disclosed are devices, methods and surgical procedures for detecting, imaging, analyzing, diagnosing and/or treating vascular disorders and related conditions of the human and mammalian body in males and/or females. In particular embodiments, treatments include methods for imaging, analyzing and improving erectile dysfunction and related conditions and potentially increasing angiogenesis in response to specifically diagnosed conditions.
    Type: Grant
    Filed: August 11, 2017
    Date of Patent: May 15, 2018
    Assignee: CARDIOVASCULAR BIOTHERAPEUTICS, INC.
    Inventors: Vance Gardner, John Jacobs, Laurence R Meyerson, Mickael Flaa
  • Publication number: 20170340266
    Abstract: Disclosed are devices, methods and surgical procedures for detecting, imaging, analyzing, diagnosing and/or treating vascular disorders and related conditions of the human and mammalian body in males and/or females. In particular embodiments, treatments include methods for imaging, analyzing and improving erectile dysfunction and related conditions and potentially increasing angiogenesis in response to specifically diagnosed conditions.
    Type: Application
    Filed: August 11, 2017
    Publication date: November 30, 2017
    Inventors: Vance GARDNER, Kenneth THOMAS, John JACOBS
  • Publication number: 20170296625
    Abstract: Methods for detecting, imaging, analyzing, diagnosing and/or treating cutaneous conditions and dermatoses such as disorders of the skin, subcutaneous tissues, mucous membranes, poorly vascularized tissues and/or other tissue disorders, including erosions, fissures, transient and/or chronic sores, burns, wounds, ulcers, lesions and infections. In particular embodiments, treatments include methods for improving skin and related tissue healing and repair, offloading of damaged tissues and/or increasing angiogenesis in response to specifically diagnosed conditions.
    Type: Application
    Filed: July 5, 2017
    Publication date: October 19, 2017
    Inventors: Vance GARDNER, Kenneth THOMAS, John JACOBS, Mickael FLAA
  • Publication number: 20170296055
    Abstract: Devices, methods, systems and procedures for localized, targeted treatment of angiogenic-based therapy in at least one region of interest in one or more layers of cardiac tissue. Various methods can include diagnosing a patient with ischemic heart disease or “at-risk” of manifesting ischemic heart disease, placing the patient into a specific angiogenic-based treatment therapy group, collecting image data, confirming image data and other diagnostic test results, developing a preoperative plan to target region of interest, inserting the catheter into a heart chamber, monitoring the distal end of the catheter tip within the heart on a visual display, contacting at least one layer of cardiac tissue, creating one or more channels in the heart tissue and/or administering the angiogenic-based therapy.
    Type: Application
    Filed: July 5, 2017
    Publication date: October 19, 2017
    Inventors: Vance GARDNER, Kenneth THOMAS, John JACOBS, Thomas STEGMANN, Mickael FLAA
  • Publication number: 20150164994
    Abstract: The invention relates to systems and methods for the diagnosis, amelioration, and treatment of ischemic tissues in patients caused by and/or resulting from diminished microvascular blood flow. Patients suffering from ischemic tissue conditions can be categorized into specific subsets that are deemed to have a potential to respond to therapy. In particular, the invention includes various therapies involving stimulation of angiogenesis, vasculogenesis, arteriogenesis and/or neovascularization so as to increase perfusion of various tissues.
    Type: Application
    Filed: December 17, 2014
    Publication date: June 18, 2015
    Inventors: Vance Gardner, Hon Yu, Kenneth A. Thomas, Thomas J. Stegmann, John W. Jacobs, Tugan Muftuler, Shadfar Bahri
  • Patent number: 8983570
    Abstract: The invention relates to methods for the diagnosis, amelioration, and treatment of back pain, particularly lumbar back pain, in particular, back pain caused by muscular abnormalities, vertebral body osteoporosis, and disc degeneration. Patients with back pain are categorized into specific subsets that are deemed to have potential to respond to therapy. In particular, the invention includes a therapy involving stimulation of neovascularization so as to increase perfusion of various spine compartments.
    Type: Grant
    Filed: March 24, 2008
    Date of Patent: March 17, 2015
    Assignee: Cardiovascular Biotherapeutics, Inc.
    Inventors: Thomas J. Stegmann, Kenneth A. Thomas, John W. Jacobs, Tugan Muftuler, Shadfar Bahri, Hon Yu, Vance Gardner
  • Publication number: 20130230454
    Abstract: Methods for the diagnosis and treatment of ischemic spinal conditions, degenerative disc disease, back pain and/or other tissue pathologies. Patients with ischemic spine disease can be categorized into subsets that are deemed to have potential to respond to therapy. In particular, therapies are disclosed which involve stimulation of neovascularization so as to increase perfusion of spinal and other anatomies.
    Type: Application
    Filed: March 15, 2013
    Publication date: September 5, 2013
    Applicant: CARDIOVASCULAR BIOTHERAPEUTICS, INC.
    Inventors: Vance Gardner, Hon Yu, Kenneth A. Thomas, Thomas J. Stegmann, John W. Jacobs, Tugan Muftuler, Shadfar Bahri, Edwin Anderson
  • Publication number: 20090076481
    Abstract: The invention relates to methods for the diagnosis, amelioration, and treatment of back pain, particularly lumbar back pain, in particular, back pain caused by muscular abnormalities, vertebral body osteoporosis, and disc degeneration. Patients with back pain are categorized into specific subsets that are deemed to have potential to respond to therapy. In particular, the invention includes a therapy involving stimulation of neovascularization so as to increase perfusion of various spine compartments.
    Type: Application
    Filed: March 24, 2008
    Publication date: March 19, 2009
    Inventors: THOMAS J. STEGMANN, KENNETH A. THOMAS, JOHN W. JACOBS, TUGAN MUFTULER, SHADFAR BAHRI, HON YU, VANCE GARDNER